LRFN4
Basic information
Region (hg38): 11:66856647-66860475
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- Pyruvate carboxylase deficiency (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LRFN4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 39 | 39 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 1 | 0 | 39 | 1 | 0 |
Highest pathogenic variant AF is 0.0000263
Variants in LRFN4
This is a list of pathogenic ClinVar variants found in the LRFN4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-66858057-G-A | not specified | Uncertain significance (Mar 01, 2024) | ||
11-66858090-C-T | not specified | Uncertain significance (Mar 16, 2024) | ||
11-66858253-C-T | not specified | Uncertain significance (Jan 29, 2024) | ||
11-66858297-C-T | not specified | Uncertain significance (Mar 20, 2024) | ||
11-66858312-G-A | not specified | Uncertain significance (May 31, 2023) | ||
11-66858373-C-T | not specified | Uncertain significance (Oct 06, 2022) | ||
11-66858388-C-T | not specified | Uncertain significance (Nov 15, 2023) | ||
11-66858390-C-A | not specified | Uncertain significance (Jun 01, 2023) | ||
11-66858396-C-T | not specified | Uncertain significance (Mar 25, 2024) | ||
11-66858408-G-A | not specified | Uncertain significance (Nov 27, 2023) | ||
11-66858484-G-A | not specified | Uncertain significance (Dec 27, 2023) | ||
11-66858489-G-C | not specified | Uncertain significance (May 02, 2024) | ||
11-66858490-C-T | not specified | Uncertain significance (Dec 16, 2021) | ||
11-66858540-C-T | not specified | Uncertain significance (May 21, 2024) | ||
11-66858560-C-T | Likely benign (Jul 01, 2022) | |||
11-66858567-G-A | not specified | Uncertain significance (Feb 16, 2023) | ||
11-66858663-G-C | not specified | Uncertain significance (Dec 14, 2023) | ||
11-66858777-G-A | not specified | Uncertain significance (Mar 30, 2022) | ||
11-66858904-C-T | not specified | Uncertain significance (May 05, 2023) | ||
11-66858915-G-A | not specified | Uncertain significance (Feb 01, 2023) | ||
11-66858921-G-A | not specified | Uncertain significance (Mar 01, 2023) | ||
11-66858924-C-T | not specified | Uncertain significance (Jan 18, 2022) | ||
11-66858944-G-T | not specified | Uncertain significance (Apr 06, 2024) | ||
11-66858990-G-A | not specified | Uncertain significance (Dec 27, 2023) | ||
11-66859020-G-A | not specified | Uncertain significance (Aug 30, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LRFN4 | protein_coding | protein_coding | ENST00000309602 | 2 | 3829 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.913 | 0.0869 | 125348 | 0 | 9 | 125357 | 0.0000359 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.25 | 347 | 419 | 0.828 | 0.0000305 | 3893 |
Missense in Polyphen | 102 | 158.2 | 0.64477 | 1669 | ||
Synonymous | -0.928 | 220 | 203 | 1.08 | 0.0000155 | 1500 |
Loss of Function | 2.98 | 1 | 12.2 | 0.0816 | 6.81e-7 | 123 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000323 | 0.0000323 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000545 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000562 | 0.0000530 |
Middle Eastern | 0.0000545 | 0.0000544 |
South Asian | 0.0000409 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Promotes neurite outgrowth in hippocampal neurons. May play a role in redistributing DLG4 to the cell periphery (By similarity). {ECO:0000250}.;
- Pathway
- Neuronal System;Synaptic adhesion-like molecules;Protein-protein interactions at synapses
(Consensus)
Recessive Scores
- pRec
- 0.112
Haploinsufficiency Scores
- pHI
- 0.300
- hipred
- Y
- hipred_score
- 0.662
- ghis
- 0.434
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.354
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Lrfn4
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- regulation of postsynaptic density assembly;synaptic membrane adhesion;regulation of presynapse assembly
- Cellular component
- plasma membrane;cell surface;glutamatergic synapse;GABA-ergic synapse;integral component of postsynaptic density membrane
- Molecular function
- protein binding